SEC Company Response from Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685) (VTGN) — Apr 10, 2020
Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685)
Date: April 10, 2020 · CIK: 0001411685 · Accession: 0001654954-20-003958
AI Filing Summary & Sentiment
File numbers found in text: 333-237514
Letter
VIA EDGAR United States Securities and Exchange Commission Attention: Jeffrey Gabor VistaGen Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-237514)
RE:
Dear Mr. Gabor,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 10:00 a.m. Eastern Standard Time on April 14, 2020, or as soon as practicable thereafter.
Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Ms. Jessica R. Sudweeks at (619) 272-7063, to confirm the exact time at which the Registration Statement was declared effective.
Very
truly yours,
VISTAGEN
THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm vtgncorresp April 10, 2020 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeffrey Gabor RE: VistaGen Therapeutics, Inc. Registration Statement on Form S-1 (File No. 333-237514) Dear Mr. Gabor, Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 10:00 a.m. Eastern Standard Time on April 14, 2020, or as soon as practicable thereafter. Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Ms. Jessica R. Sudweeks at (619) 272-7063, to confirm the exact time at which the Registration Statement was declared effective. Very truly yours, VISTAGEN THERAPEUTICS, INC. /s/ Shawn K. Singh Shawn K. Singh President and Chief Executive Officer cc: Jessica R. Sudweeks Partner Disclosure Law Group, a Professional Corporation